CME Group Inc. (NASDAQ:CME) Shares Sold by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. lowered its position in CME Group Inc. (NASDAQ:CME) by 77.6% in the third quarter, Holdings Channel.com reports. The firm owned 5,894 shares of the financial services provider’s stock after selling 20,369 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in CME Group were worth $1,300,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in CME. Salomon & Ludwin LLC purchased a new position in shares of CME Group in the 1st quarter valued at about $28,000. Y.D. More Investments Ltd acquired a new position in CME Group during the second quarter worth about $36,000. McClarren Financial Advisors Inc. increased its holdings in CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after buying an additional 78 shares in the last quarter. Asset Dedication LLC lifted its position in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 170 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. boosted its stake in shares of CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after acquiring an additional 74 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Down 0.4 %

CME stock opened at $226.17 on Wednesday. CME Group Inc. has a one year low of $190.70 and a one year high of $230.12. The stock has a market capitalization of $81.44 billion, a P/E ratio of 25.73, a PEG ratio of 7.76 and a beta of 0.55. The company has a 50 day moving average price of $217.70 and a two-hundred day moving average price of $208.53. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the firm posted $2.30 earnings per share. The business’s quarterly revenue was up 12.7% compared to the same quarter last year. As a group, sell-side analysts expect that CME Group Inc. will post 10.04 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio is currently 52.33%.

Insider Transactions at CME Group

In related news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. Morgan Stanley raised their price objective on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Oppenheimer raised their price target on CME Group from $228.00 to $245.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Citigroup boosted their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Piper Sandler raised their target price on shares of CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a report on Tuesday, October 8th. Finally, Keefe, Bruyette & Woods upped their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $220.07.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.